Guangbo Kang
123 St Stephens Green, 2
Dublin, L, Ireland
Dublin, L, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Dual-mechanism anti-CD73 antibodies CR201 and CR202 targeting distinct domains for cancer immunotherapy.
Journal: Frontiers in immunology
Published: April 21, 2026
Integrative multi-omics analysis identifies ATAD1 as a potential regulator of metastasis in pancreatic cancer.
Journal: Scientific reports
Published: November 27, 2025
Propionate-engineered probiotics reduce radiation-induced intestinal damage.
Journal: Bioresources and bioprocessing
Published: November 10, 2025
Engineering probiotics as living biotherapeutics: a novel paradigm of restoring physiological barriers via targeted short-chain fatty acid delivery.
Journal: Science China. Life sciences
Published: October 07, 2025
Development and characterization of CR101-ADC, a fully-human anti-claudin18.2 monoclonal antibody-drug conjugate.
Journal: International journal of biological macromolecules
Published: September 15, 2025
Bacterial Armory: Engineering Dual Photosensitized Bacteria for a Triple-Modal Therapy on Tumors.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: September 14, 2025
Synthetic microbial consortia based on quorum-sensing for disease therapy.
Journal: Bioresources and bioprocessing
Published: July 19, 2025
An Engineered Probiotic Consortium Based on Quorum-Sensing for Colorectal Cancer Immunotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 08, 2025
Flexible Regulation of Optical Properties Based on Structure Size-Driven Intermolecular Interactions for Phototherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 22, 2025
Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis.
Journal: Pharmacological research
Published: December 23, 2024
Noncanonical amino acid-aided synthesis of anti-PD-L1 bispecific nanobody for colon cancer immunotherapy.
Journal: Communications biology
Published: December 12, 2024
Last Updated: 09/26/2026